NPAT, according to the CEO, answering a shareholder question on the Half Year results call, the R&D Expenditure going forward will be focused on what customers want rather than spend/develop and hope customers take up the new offering.
In fact the CEO said that going forward some R&D is co-funded by the client. So it seems this is the new permanent approach to R&D expenditure and therefore IRI should see a step change down in the spend and as a consequence a corresponding increase in NPAT.
Cheers…..D
NPAT, according to the CEO, answering a shareholder question on...
Add IRI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
60.0¢ |
Change
-0.025(4.00%) |
Mkt cap ! $104.7M | |||
| Open | High | Low | Value | Volume |
| 60.0¢ | 63.0¢ | 60.0¢ | $605.3K | 988.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 27000 | 59.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 61.0¢ | 5927 | 3 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| IRI (ASX) Chart |